Probotics: A Promising Solution for Irritable Bowel Syndrome (Ibs)

Abstract

Irritable Bowel Syndrome (IBS) is a distressing functional gastrointestinal disorder that is increasingly recognized as a condition involving both the gut and the brain. In today's healthcare landscape, probiotics have become a common component of many people's wellness routines, independent of prescribed medications. There is substantial evidence supporting the potential of probiotics to provide therapeutic benefits for individuals dealing with irritable bowel syndrome. Recent studies emphasize the pivotal role of the microbial factor in the pathophysiology of IBS, as some research has identified significant alterations in the gut microbiome of individuals with IBS. Consequently, the impact of probiotics on IBS patients is under intense investigation in the current era of probiotic research. The precise mechanisms of action are not yet fully understood, but presently, probiotic products tailored for IBS relief are readily available in the market and have shown the potential to alleviate symptoms effectively. Evidence suggested that strains of Lactobacillus species, strains of Pediococcus species and Bifidibacterium species may show effective results in some patients of IBS. The aim of this study is to uncover potential causative factors contributing to IBS and to explore the use of probiotics as an efficacious treatment approach for IBS.